Skip to main content

Topiramate

NDC 70771-1316 · Zydus Lifesciences Limited

Generic nameTopiramate
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
Active ingredient(s)TOPIRAMATE
Strength50 mg/1
Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

70771-1316-1 — 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1316-1)

70771-1316-3 — 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1316-3)

70771-1316-4 — 10 BLISTER PACK in 1 CARTON (70771-1316-4) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (70771-1316-2)

70771-1316-5 — 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1316-5)

70771-1316-9 — 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1316-9)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70710-1039 — Topiramate, 70710-1040 — Topiramate, 70710-1041 — Topiramate, 70710-1042 — Topiramate, 70710-1043 — Topiramate, 70748-275 — Topiramate, 70748-276 — Topiramate, 70748-277 — Topiramate, 70748-278 — Topiramate, 70771-1315 — Topiramate, 70771-1317 — Topiramate, 70771-1656 — Topiramate, 70771-1657 — Topiramate, 70771-1658 — Topiramate, 70771-1659 — Topiramate, 70771-1660 — Topiramate, 70771-1858 — Topiramate, 71205-187 — topiramate, 71205-195 — topiramate, 71205-202 — topiramate, +289 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels